Cross-linked and non-cross-linked HA
Cross-linking creates chemical connections between HA chains and can make an injectable gel persist longer. BDDE (1,4-butanediol diglycidyl ether) is one cross-linking reagent studied in HA fillers. Non-cross-linked HA does not have that same chemical network. Other approaches to stabilisation exist, so ask what the finished formulation contains rather than interpreting a marketing name alone.
What the label does not tell you
The reagent used during manufacture, the HA network it produces and any unreacted residual material are distinct questions. In a laboratory comparison of four BDDE gels, conventional measurements did not neatly track the chemistry and hydration changed the ranking of their properties. A cross-linking percentage is therefore not a universal durability or safety score. The exact product’s clinical evidence and instructions still matter.
Questions to bring
Which stabilisation or cross-linking approach does this formulation use? Can you explain why its finished gel properties fit the intended area? What product-specific safety, impurity and clinical data are available? What are the options and limitations if reduction or removal becomes necessary?
Evidence and scope
The chemistry paper is an in-vitro material study, not a head-to-head clinical result or a recommendation of a brand.
Read the original sources
Sources describe specific products, studies or countries. They do not establish approval everywhere.
General education. Your clinician can assess your individual suitability. Rules depend on the treatment country; FDA references concern the United States. External sources may be in another language.